Certain New Chemicals or Significant New Uses; Statements of Findings for January 2021, 23722-23723 [2021-09369]
Download as PDF
<![CDATA[
23722
Federal Register / Vol. 86, No. 84 / Tuesday, May 4, 2021 / Notices
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2021–0146; FRL–10021–
51]
Certain New Chemicals or Significant
New Uses; Statements of Findings for
January 2021
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Toxic Substances Control
Act (TSCA) requires EPA to publish in
the Federal Register a statement of its
findings after its review of TSCA notices
when EPA makes a finding that a new
chemical substance or significant new
use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to premanufacture notices (PMNs),
microbial commercial activity notices
(MCANs), and significant new use
notices (SNUNs) submitted to EPA
under TSCA. This document presents
statements of findings made by EPA on
TSCA notices during the period from
January 1, 2021 to January 31, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Rebecca Edelstein, New Chemicals
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 564–1667;
email address: edelstein.rebecca@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPPT
Docket is (202) 566–0280. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of
findings made by EPA after review of
notices submitted under TSCA section
5(a) that certain new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment. This document presents
statements of findings made by EPA
during the period from January 1, 2021
to January 31, 2021.
III. What is the Agency’s authority for
taking this action?
TSCA section 5(a)(3) requires EPA to
review a TSCA section 5(a) notice and
make one of the following specific
findings:
Æ The chemical substance or
significant new use presents an
unreasonable risk of injury to health or
the environment;
Æ The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects of the chemical
substance or significant new use;
Æ The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects and the chemical
substance or significant new use may
SUPPLEMENTARY INFORMATION:
present an unreasonable risk of injury to
health or the environment;
I. General Information
Æ The chemical substance is or will
A. Does this action apply to me?
be produced in substantial quantities,
and such substance either enters or may
This action is directed to the public
reasonably be anticipated to enter the
in general. As such, the Agency has not
environment in substantial quantities or
attempted to describe the specific
there is or may be significant or
entities that this action may apply to.
substantial human exposure to the
Although others may be affected, this
action applies directly to the submitters substance; or
Æ The chemical substance or
of the PMNs addressed in this action.
significant new use is not likely to
B. How can I get copies of this document
present an unreasonable risk of injury to
and other related information?
health or the environment.
Unreasonable risk findings must be
The docket for this action, identified
made without consideration of costs or
by docket identification (ID) number
EPA–HQ–OPPT–2021–0146, is available other non-risk factors, including an
unreasonable risk to a potentially
at https://www.regulations.gov or at the
exposed or susceptible subpopulation
Office of Pollution Prevention and
identified as relevant under the
Toxics Docket (OPPT Docket),
VerDate Sep<11>2014
17:13 May 03, 2021
Jkt 253001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
conditions of use. The term ‘‘conditions
of use’’ is defined in TSCA section 3 to
mean ‘‘the circumstances, as determined
by the Administrator, under which a
chemical substance is intended, known,
or reasonably foreseen to be
manufactured, processed, distributed in
commerce, used, or disposed of.’’
EPA is required under TSCA section
5(g) to publish in the Federal Register
a statement of its findings after its
review of a TSCA section 5(a) notice
when EPA makes a finding that a new
chemical substance or significant new
use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to PMNs, MCANs, and SNUNs
submitted to EPA under TSCA section
5.
Anyone who plans to manufacture
(which includes import) a new chemical
substance for a non-exempt commercial
purpose and any manufacturer or
processor wishing to engage in a use of
a chemical substance designated by EPA
as a significant new use must submit a
notice to EPA at least 90 days before
commencing manufacture of the new
chemical substance or before engaging
in the significant new use.
The submitter of a notice to EPA for
which EPA has made a finding of ‘‘not
likely to present an unreasonable risk of
injury to health or the environment’’
may commence manufacture of the
chemical substance or manufacture or
processing for the significant new use
notwithstanding any remaining portion
of the applicable review period.
IV. Statements of Administrator
Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the
following information (to the extent that
such information is not claimed as
Confidential Business Information
(CBI)) on the PMNs, MCANs and
SNUNs for which, during this period,
EPA has made findings under TSCA
section 5(a)(3)(C) that the new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment:
Æ EPA case number assigned to the
TSCA section 5(a) notice.
Æ Chemical identity (generic name if
the specific name is claimed as CBI).
Æ Website link to EPA’s decision
document describing the basis of the
‘‘not likely to present an unreasonable
risk’’ finding made by EPA under TSCA
section 5(a)(3)(C).
E:\FR\FM\04MYN1.SGM
04MYN1
23723
Federal Register / Vol. 86, No. 84 / Tuesday, May 4, 2021 / Notices
EPA case No.
Chemical identity
J–20–0025 ..........................................................
P–21–0012 .........................................................
P–20–0185 .........................................................
P–20–0107 .........................................................
J–20–0013, J–20–0014, J–20–0015,
0016, J–20–0017, J–20–0018.
J–20–
J–20–0005 ..........................................................
Authority: 15 U.S.C. 2601 et seq.
[FR Doc. 2021–09369 Filed 5–3–21; 8:45 am]
BILLING CODE 6560–50–P
EXPORT-IMPORT BANK
[Public Notice: 2021–6006]
Agency Information Collection
Activities: Comment Request
Export-Import Bank of the
United States.
ACTION: Submission for OMB review and
comments request.
AGENCY:
The Export-Import Bank of
the United States (EXIM), as a part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
Agencies to comment on the proposed
information collection, as required by
the Paperwork Reduction Act of 1995.
DATES: Comments must be received on
or before July 6, 2021 to be assured of
consideration.
ADDRESSES: Comments may be
submitted electronically on
www.regulations.gov or by mail to
Donna Schneider, Export-Import Bank
of the United States, 811 Vermont Ave.
NW, Washington, DC 20571.
Form can be viewed at https://
www.exim.gov/sites/default/files/pub/
pending/eib10_03-1.pdf.
FOR FURTHER INFORMATION CONTACT: To
request additional information, please
Donna Schneider. 202–565–3612.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:13 May 03, 2021
Jkt 253001
Biofuel producing Saccharomyces cerevisiae https://www.epa.gov/reviewing-new-chemicalsmodified, genetically stable (Generic Name).
under-toxic-substances-control-act-tsca/
tsca-section-5a3c-determination-494.
Multialkylbicycloalkenyl
substituted https://www.epa.gov/reviewing-new-chemicalspropanenitrile (Generic Name).
under-toxic-substances-control-act-tsca/
tsca-section-5a3c-determination-493.
Amines, C36-alkylenedi-, polymers with https://www.epa.gov/reviewing-new-chemicalsbicyclo[2.2.1]heptanedimethanamine, [5,5’under-toxic-substances-control-act-tsca/
biisobenzofuran]-1,1’,3,3’-tetrone
and
tsca-section-5a3c-determination-491.
3a,4,5,7atetrahydro-7-methyl-5-(tetrahydro2,5-dioxo-3-furanyl)-1,3-isobenzofurandione,
maleated: CASRN 2414426–71–2.
Carbimide, polyalkylenepolyarylene ester, https://www.epa.gov/reviewing-new-chemicalspolymer with 1,2-alkanediol, 2-alkoxyalkyl
under-toxic-substances-control-act-tsca/
methacrylateand
3-(2-alkoxyalkyl)-2tsca-section-5a3c-determination-490.
heterocycle-blocked (Generic Name).
Strains of Escherichia coli modified with ge- https://www.epa.gov/reviewing-new-chemicalsnetically-stable, plasmid-borne DNA for the
under-toxic-substances-control-act-tsca/
production of enzymes (Generic Names).
tsca-section-5a3c-determination-489.
Saccharomyces cerevisiae modified (Generic https://www.epa.gov/reviewing-new-chemicalsName).
under-toxic-substances-control-act-tsca/
tsca-section-5a3c-determination-488.
This
collection of information is necessary,
pursuant to 12 U.S.C. 635 (a)(1), to
determine eligibility of the export sales
for insurance coverage. The Report of
Premiums Payable for Financial
Institutions Only is used to determine
the eligibility of the shipment(s) and to
calculate the premium due to Ex-Im
Bank for its support of the shipment(s)
under its insurance program. ExportImport Bank customers will be able to
submit this form on paper or
electronically.
By neutralizing the effect of export
credit support offered by foreign
governments and by absorbing credit
risks that the private sector will not
accept, EXIM enables U.S. exporters to
compete fairly in foreign markets on the
basis of price and product. Under the
Working Capital Guarantee Program,
EXIM provides repayment guarantees to
lenders on secured, short-term working
capital loans made to qualified
exporters. The guarantee may be
approved for a single loan or a revolving
line of credit. In the event that a buyer
defaults on a transaction insured by
EXIM the insured exporter or lender
may seek payment by the submission of
a claim.
Title and Form Number: EIB 10–03
Notice of Claim and Proof of Loss,
Export Credit Insurance Policies.
OMB Number: 3048–0033.
Type of Review: Regular.
Need and Use: This collection of
information is necessary, pursuant to 12
U.S.C. 635(a)(1), to determine if such
claim complies with the terms and
conditions of the relevant insurance
policy.
SUPPLEMENTARY INFORMATION:
Dated: April 6, 2021.
Madison H. Le,
Director, New Chemicals Division, Office of
Pollution Prevention and Toxics.
Website link
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Affected Public: This form affects
entities involved in the export of U.S.
goods and services.
Annual Number of Respondents: 300.
Estimated Time per Respondent: 60
minutes.
Annual Burden Hours: 300 hours.
Frequency of Reporting or Use: As
needed to request claim payment.
Government Expenses
Reviewing Time per Year: 300 hours.
Average Wages per Hour: $42.50.
Average Cost per Year: $12,750.
Benefits and Overhead: 20%.
Total Government Cost: $15,300.
Bassam Doughman,
IT Specialist.
[FR Doc. 2021–09389 Filed 5–3–21; 8:45 am]
BILLING CODE 6690–01–P
FEDERAL FINANCIAL INSTITUTIONS
EXAMINATION COUNCIL
[Docket No. AS21–04]
Appraisal Subcommittee Notice of
Meeting
Appraisal Subcommittee of the
Federal Financial Institutions
Examination Council.
ACTION: Notice of Meeting.
AGENCY:
Description: In accordance with
Section 1104 (b) of Title XI of the
Financial Institutions Reform, Recovery,
and Enforcement Act of 1989, as
amended, notice is hereby given that the
Appraisal Subcommittee (ASC) will
meet in open session for a special
meeting:
Location: Due to the COVID–19
Pandemic, the meeting will be open to
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 86, Number 84 (Tuesday, May 4, 2021)]
[Notices]
[Pages 23722-23723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09369]
[[Page 23722]]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2021-0146; FRL-10021-51]
Certain New Chemicals or Significant New Uses; Statements of
Findings for January 2021
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to
publish in the Federal Register a statement of its findings after its
review of TSCA notices when EPA makes a finding that a new chemical
substance or significant new use is not likely to present an
unreasonable risk of injury to health or the environment. Such
statements apply to premanufacture notices (PMNs), microbial commercial
activity notices (MCANs), and significant new use notices (SNUNs)
submitted to EPA under TSCA. This document presents statements of
findings made by EPA on TSCA notices during the period from January 1,
2021 to January 31, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Rebecca Edelstein, New Chemicals
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: (202) 564-1667; email address:
[email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. As such, the
Agency has not attempted to describe the specific entities that this
action may apply to. Although others may be affected, this action
applies directly to the submitters of the PMNs addressed in this
action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPPT-2021-0146, is available at https://www.regulations.gov or at the Office of Pollution Prevention and Toxics
Docket (OPPT Docket), Environmental Protection Agency Docket Center
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280. Please review the visitor instructions and additional information
about the docket available at https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of findings made by EPA after
review of notices submitted under TSCA section 5(a) that certain new
chemical substances or significant new uses are not likely to present
an unreasonable risk of injury to health or the environment. This
document presents statements of findings made by EPA during the period
from January 1, 2021 to January 31, 2021.
III. What is the Agency's authority for taking this action?
TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a)
notice and make one of the following specific findings:
[cir] The chemical substance or significant new use presents an
unreasonable risk of injury to health or the environment;
[cir] The information available to EPA is insufficient to permit a
reasoned evaluation of the health and environmental effects of the
chemical substance or significant new use;
[cir] The information available to EPA is insufficient to permit a
reasoned evaluation of the health and environmental effects and the
chemical substance or significant new use may present an unreasonable
risk of injury to health or the environment;
[cir] The chemical substance is or will be produced in substantial
quantities, and such substance either enters or may reasonably be
anticipated to enter the environment in substantial quantities or there
is or may be significant or substantial human exposure to the
substance; or
[cir] The chemical substance or significant new use is not likely
to present an unreasonable risk of injury to health or the environment.
Unreasonable risk findings must be made without consideration of
costs or other non-risk factors, including an unreasonable risk to a
potentially exposed or susceptible subpopulation identified as relevant
under the conditions of use. The term ``conditions of use'' is defined
in TSCA section 3 to mean ``the circumstances, as determined by the
Administrator, under which a chemical substance is intended, known, or
reasonably foreseen to be manufactured, processed, distributed in
commerce, used, or disposed of.''
EPA is required under TSCA section 5(g) to publish in the Federal
Register a statement of its findings after its review of a TSCA section
5(a) notice when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to PMNs,
MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture (which includes import) a new
chemical substance for a non-exempt commercial purpose and any
manufacturer or processor wishing to engage in a use of a chemical
substance designated by EPA as a significant new use must submit a
notice to EPA at least 90 days before commencing manufacture of the new
chemical substance or before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding
of ``not likely to present an unreasonable risk of injury to health or
the environment'' may commence manufacture of the chemical substance or
manufacture or processing for the significant new use notwithstanding
any remaining portion of the applicable review period.
IV. Statements of Administrator Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the following information (to the extent
that such information is not claimed as Confidential Business
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this
period, EPA has made findings under TSCA section 5(a)(3)(C) that the
new chemical substances or significant new uses are not likely to
present an unreasonable risk of injury to health or the environment:
[cir] EPA case number assigned to the TSCA section 5(a) notice.
[cir] Chemical identity (generic name if the specific name is
claimed as CBI).
[cir] Website link to EPA's decision document describing the basis
of the ``not likely to present an unreasonable risk'' finding made by
EPA under TSCA section 5(a)(3)(C).
[[Page 23723]]
------------------------------------------------------------------------
EPA case No. Chemical identity Website link
------------------------------------------------------------------------
J-20-0025................... Biofuel producing https://www.epa.gov/
Saccharomyces reviewing-new-
cerevisiae chemicals-under-
modified, toxic-substances-
genetically stable control-act-tsca/
(Generic Name). tsca-section-5a3c-
determination-494.
P-21-0012................... Multialkylbicycloalk https://www.epa.gov/
enyl substituted reviewing-new-
propanenitrile chemicals-under-
(Generic Name). toxic-substances-
control-act-tsca/
tsca-section-5a3c-
determination-493.
P-20-0185................... Amines, C36- https://www.epa.gov/
alkylenedi-, reviewing-new-
polymers with chemicals-under-
bicyclo[2.2.1]hepta toxic-substances-
nedimethanamine, control-act-tsca/
[5,5'- tsca-section-5a3c-
biisobenzofuran]- determination-491.
1,1',3,3'-tetrone
and
3a,4,5,7atetrahydro-
7-methyl-5-
(tetrahydro-2,5-
dioxo-3-furanyl)-
1,3-
isobenzofurandione,
maleated: CASRN
2414426-71-2.
P-20-0107................... Carbimide, https://www.epa.gov/
polyalkylenepolyary reviewing-new-
lene ester, polymer chemicals-under-
with 1,2- toxic-substances-
alkanediol, 2- control-act-tsca/
alkoxyalkyl tsca-section-5a3c-
methacrylate- and 3- determination-490.
(2-alkoxyalkyl)-2-
heterocycle-blocked
(Generic Name).
J-20-0013, J-20-0014, J-20- Strains of https://www.epa.gov/
0015, J-20-0016, J-20-0017, Escherichia coli reviewing-new-
J-20-0018. modified with chemicals-under-
genetically-stable, toxic-substances-
plasmid-borne DNA control-act-tsca/
for the production tsca-section-5a3c-
of enzymes (Generic determination-489.
Names).
J-20-0005................... Saccharomyces https://www.epa.gov/
cerevisiae modified reviewing-new-
(Generic Name). chemicals-under-
toxic-substances-
control-act-tsca/
tsca-section-5a3c-
determination-488.
------------------------------------------------------------------------
Authority: 15 U.S.C. 2601 et seq.
Dated: April 6, 2021.
Madison H. Le,
Director, New Chemicals Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2021-09369 Filed 5-3-21; 8:45 am]
BILLING CODE 6560-50-P
